Search by Drug Name or NDC
NDC 51655-0570-25 clonidine hydrochloride 0.1 mg/1 Details
clonidine hydrochloride 0.1 mg/1
clonidine hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is CLONIDINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Clonidine tablets (Catapres) are used alone or in combination with other medications to treat high blood pressure. Clonidine extended-release (long-acting) tablets (Kapvay) are used alone or in combination with other medications as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in children. Clonidine is in a class of medications called centrally acting alpha-agonist hypotensive agents. Clonidine treats high blood pressure by decreasing your heart rate and relaxing the blood vessels so that blood can flow more easily through the body. Clonidine extended-release tablets may treat ADHD by affecting the part of the brain that controls attention and impulsivity. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 51655-0570-25Last Updated: 04/21/2024
MedLinePlus Full Drug Details: Clonidine
Product Information
| NDC | 51655-0570 |
|---|---|
| Product ID | 51655-570_dae7e933-abb9-469d-e053-2a95a90a5030 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | clonidine hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | clonidine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.1 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Labeler Name | Northwind Pharmaceuticals |
| Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078895 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51655-0570-25 (51655057025)
| NDC Package Code | 51655-570-25 |
|---|---|
| Billing NDC | 51655057025 |
| Package | 60 TABLET in 1 BOTTLE, PLASTIC (51655-570-25) |
| Marketing Start Date | 2021-02-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |